Yoshimura Tomoaki

Affiliation and department：

Research field (1)： Clinical pharmacy

Papers (158)：

Yoshihiro Noguchi, Miao Yan, Tomoya Tachi, Tomoaki Yoshimura. Correspondence on 'Cardiovascular toxicities associated with bispecific T-cell engager therapy' by Sayedet al. Journal for ImmunoTherapy of Cancer. 2024. 12. 4. e009137-e009137
Go M, Noguchi Y, Masuda R, Asano H, Kimura M, Usami E, Yoshimura T. Association between CDK4/6 Inhibitors and Drug-Related Osteonecrosis of the Jaw: A Pharmacoepidemiological Study using the FDA Adverse Events Reporting System. International Journal of Cancer. 2024
Yoshihiro Noguchi, Tomoaki Yoshimura. Detection Algorithms for Simple Two-Group Comparisons Using Spontaneous Reporting Systems. Drug Safety. 2024
Shunsuke Yoshizawa, Tomoya Tachi, Yuta Takahashi, Satoshi Aoyama, Yoshihiro Noguchi, Kazuhide Tanaka, Masahiro Yasuda, Takashi Mizui, Hisao Komeda, Tomoaki Yoshimura, et al. Impact of Polypharmacy and Risk Factors for Exacerbation of Lower Urinary Tract Symptoms in Patients with Urological Conditions: A Retrospective Study in a Japanese Municipal Hospital. Biological & pharmaceutical bulletin. 2024. 47. 4. 818-826
Hiroki Asano, Yoshihiro Noguchi, Michio Kimura, Eiseki Usami, Tomoaki Yoshimura. Pituitary-Related Adverse Events and Onset Patterns Caused by Immune Checkpoint Inhibitors: Analysis Using the Japanese Adverse Drug Event Report Database. Medicina. 2023. 59. 11. 1963-1963

ｍore...

MISC (1)：

宇佐美英績, 木村美智男, 飯原大稔, 谷澤克弥, 大澤友裕, 兼松哲史, 平出耕石, 吉村知哲. 岐阜県におけるがん研修制度を利用した臨床研究マインドの育成. 日本病院薬剤師会雑誌. 2020. 56. 11. 1335-1339

Books (25)：

ｍore...

Education (2)：

Work history (3)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page